NasdaqCM - Delayed Quote USD
enGene Holdings Inc. (ENGN)
2.8800
-0.0900
(-3.03%)
At close: May 13 at 4:00:02 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 6.92M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF UA Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.90 per share. | Indirect | 4,999,993 | Oct 30, 2024 |
FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF UA Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.94 - 9.09 per share. | Direct | 3,012,674 | Oct 8, 2024 |
COOPER RONALD HAROLD WILFRED Chief Executive Officer | Purchase at price 5.70 per share. | Direct | 57,000 | Sep 27, 2024 |
GLICKMAN RICHARD M Director | Conversion of Exercise of derivative security at price 0.89 per share. | Direct | 107 | May 28, 2024 |
FONDS DE SOLIDARITE DES TRAVAILLEURS DU Beneficial Owner of more than 10% of a Class of Security | Sale at price 15.00 - 15.01 per share. | Direct | 787,981 | Apr 22, 2024 |
CHEUNG ANTHONY TZEYEW Chief Technology Officer | Conversion of Exercise of derivative security at price 0.89 per share. | Direct | 47,117 | Mar 18, 2024 |
BRUNK GERALD A Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 15.19 per share. | Indirect | 12,152,000 | Feb 20, 2024 |
LUMIRA CAPITAL INVESTMENT MANAGEMENT INC Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 15.19 per share. | Indirect | 12,152,000 | Feb 20, 2024 |
BRUNK GERALD A Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Oct 31, 2023 |
GLICKMAN RICHARD M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 31, 2023 |
CHEUNG ANTHONY TZEYEW Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 31, 2023 |
FORBION GROWTH SPONSOR FEAC I B.V. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Oct 27, 2023 |
Related Tickers
ELVN Enliven Therapeutics, Inc.
20.03
+5.37%
SRZN Surrozen, Inc.
7.20
-10.00%
IPSC Century Therapeutics, Inc.
0.5260
+0.25%
EPRX.TO Eupraxia Pharmaceuticals Inc.
5.30
-0.56%
ABVX ABIVAX Société Anonyme
6.04
-5.63%
DNTH Dianthus Therapeutics, Inc.
18.84
-6.18%
TYRA Tyra Biosciences, Inc.
9.98
-2.73%
ERAS Erasca, Inc.
1.3300
-4.32%
7R8.BE Replimune Group Inc
6.55
-8.39%
FHTX Foghorn Therapeutics Inc.
4.3300
-2.26%